News
Business
Economy
Politics
Technology
Environment
Search
Sunday, January 12, 2025
No menu items!
News
Business
Economy
Politics
Technology
Environment
Search
Home
Gilead buys out rights to cancer therapy from Jounce for $67 million
FILE PHOTO: The logo of Gilead Sciences Inc pharmaceutical company
FILE PHOTO: The logo of Gilead Sciences Inc pharmaceutical company
FILE PHOTO: The logo of Gilead Sciences Inc pharmaceutical company is seen in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
- Advertisment -
Most Read
Trump, Zuckerberg meet at Mar-a-Lago, Semafor reports
January 12, 2025
Biden says still pondering preemptive pardons, believes he could have beaten Trump in 2024
January 12, 2025
Trump’s Middle East envoy meets Netanyahu on Saturday amid ceasefire push
January 12, 2025
Apple’s board recommends shareholders vote against proposal to eliminate diversity programs
January 12, 2025
We use cookies to ensure that we give you the best experience on our website.
Ok